Novartis to present Gilenya data at neurology conference

ZURICH, March 13 Wed Mar 13, 2013 2:26am EDT

Related Topics

ZURICH, March 13 (Reuters) - Novartis said data on multiple sclerosis drug Gilenya will be presented at an upcoming neurology conference.

Three late-stage clinical studies on the drug will be presented to the American Academy of Neurology American Academy of Neurology, which takes place March 16 to 23. (Reporting By Katharina Bart)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.